As a general practitioner, I have witnessed firsthand the escalating tide of overmedication that plagues modern healthcare. Patients arrive clutching bags of tablets, many of which they have taken for years without question. The default assumption has become that more pills equal better health, but this is a dangerous fallacy. De-prescribing—the careful reduction or cessation of medications that are no longer needed or may be causing harm—must become a core skill for every GP.
The Scale of the Problem
Studies show that up to 50% of patients taking five or more medications are on at least one that is potentially inappropriate. Older adults, in particular, are vulnerable to polypharmacy, where drug interactions and side effects can outweigh benefits. Falls, cognitive impairment, and hospital admissions are often linked to unnecessary pills. Yet the culture of prescribing persists, driven by time pressures, patient expectations, and a pharmaceutical industry that profits from lifelong consumption.
Why De-Prescribing Matters
De-prescribing is not about denying treatment but about optimizing it. It requires a systematic approach: reviewing each medication's indication, expected benefit, and risk, especially in the context of a patient's current health and goals. For example, a statin started for primary prevention in a 90-year-old with advanced dementia may no longer serve a meaningful purpose. Similarly, proton pump inhibitors are often continued indefinitely without reassessment, increasing the risk of fractures and infections.
The benefits of de-prescribing are clear. Patients report improved quality of life, fewer side effects, and greater satisfaction. Healthcare systems save money and resources. But the barriers are formidable. Many clinicians lack training in how to taper medications safely. Patients may feel abandoned or distrustful when a drug is stopped. And there is little financial incentive for practices to spend time on medication reviews.
A Call for Change
We need a cultural shift. Medical education must emphasize de-prescribing as a fundamental clinical skill. Guidelines should include explicit advice on when to stop medications, not just when to start them. Consultations should routinely incorporate medication reviews, with patients empowered to ask: “Do I still need this?”
Technology can help. Electronic health records could flag potentially inappropriate combinations and prompt reviews. Pharmacists could play a greater role in medication reconciliation. But ultimately, it is the relationship between doctor and patient that matters most. Honest conversations about the limits of medicine and the risks of polypharmacy are long overdue.
I have seen patients transform after de-prescribing: their confusion clears, their energy returns, and they regain a sense of control. It is a reminder that sometimes the best medicine is no medicine at all. We must embrace de-prescribing not as a failure of treatment, but as a triumph of thoughtful, patient-centered care.
